Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Emedastine Difumarate is a selective histamine H1 receptor antagonist with anti-allergic activity, prescribed for allergic conjunctivitis. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 970.00 |
Description | Emedastine Difumarate is a selective histamine H1 receptor antagonist with anti-allergic activity, prescribed for allergic conjunctivitis. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. |
Targets&IC50 | H2 receptor:49067 nM (Ki), H3 receptor:12430 nM (Ki), H1 receptor:1.3 nM (Ki) |
Synonyms | Rapimine, DSSTox_CID_26911, AL-3432A, KB-2413, Emedastine fumarate, KB 2413 |
Molecular Weight | 534.56 |
Formula | C25H34N4O9 |
CAS No. | 87233-62-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Emedastine Difumarate 87233-62-3 KB2413 Rapimine DSSTox_CID_26911 AL-3432A Emedastine Fumarate KB-2413 Emedastine fumarate Emedastine KB 2413 inhibitor inhibit